Clinical trial
Study of Tongxinluo to Improve High on Clopidogrel Platelet Reactivity in Patients With Coronary Heart Disease
NCT01721590 is registered in ClinicalTrials.gov with Han Yaling as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Tongxinluo to Improve High on Clopidogrel Platelet Reactivity in Patients With Coronary Heart Disease
- Lead sponsor
- Han Yaling
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2012
- Completion date
- June 30, 2014
- Enrollment
- 134 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.